Search programmes

Therapeutic area

  • Hemostasis and bleeding disorders (43)

CONNECT

Format

Duration

Accreditation

Programmes in Hemostasis and bleeding disorders

Showing 1 to 6 of 43 results
Show filters filter
podcast Podcast

Episode

4

of 4

episode
Hemostasis and bleeding disorders 
Perioperative thromboprophylaxis revisited

Minimising the risk of thrombosis in surgical patients

Experts
Prof. Dimitrios Tsakiris, Prof. Daniel Bolliger
  • download Downloadable
    Resouces
  • clock 19 MIN
  • calendar Nov 2023

Educational programme supported by an independent medical education grant from Viatris.
podcast Podcast

Episode

3

of 4

episode
Hemostasis and bleeding disorders 
VTE: What is the optimal duration of antithrombotic treatment?

Part 3 of a 4-part series on thrombosis

Experts
Prof. Dimitrios Tsakiris, Prof. Jerzy Windyga
Endorsed by
Fundacja Trombofilia i Zakrzepica
  • download Downloadable
    Resouces
  • clock 26 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Viatris.
podcast Podcast

Episode

2

of 4

episode
Hemostasis and bleeding disorders Oncology 
Cancer and Thrombosis

A podcast discussion on treating thrombosis in patients with cancer

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis
  • download Downloadable
    Resouces
  • clock 27 MIN
  • calendar Sep 2023

Educational programme supported by an independent medical education grant from Viatris.
e-learning Interactive e-learning
Hemostasis and bleeding disorders 
Normalising Haemostasis in Haemophilia: Panel Discussion and E-learning

Will the expert panellists change the way you think about managing haemophilia?

Experts
Prof. Pål Andrè Holme, Prof. Niamh O'Connell, Assoc. Prof. Jan Blatný
  • download Downloadable
    Resouces
  • clock 45 MIN
  • calendar Sep 2023

Educational programme supported by an independent medical education grant from Sobi.
podcast Podcast

Episode

1

of 4

episode
Hemostasis and bleeding disorders 
Monitoring Anticoagulation: Yes or No?

A clinical discussion on anticoagulation monitoring

Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler
  • download Downloadable
    Resouces
  • clock 20 MIN
  • calendar Aug 2023

Educational programme supported by an independent medical education grant from Viatris
video Video
Hemostasis and bleeding disorders 
How Coagulation Cascade Deficiencies Lead to Bleeding Disorders

A short video from bleeding disorder experts

Experts
Dr Vickie McDonald, Prof. Ana Boban
  • clock 4 MIN
  • calendar Jul 2023

Educational programme supported by an independent medical education grant from Takeda

Hemostasis is a complex physiological process that entails preventing blood loss from damaged vessels. It is a dynamic balance of anti-coagulation and pro-coagulation molecules and consists of three sequential processes.

Primary hemostasis

The interaction between the damaged endothelium, von Willebrand factor (VWF), and platelets is a vital process for the development of a platelet plug at the injury site.

Secondary hemostasis

The coagulation cascade is initiated on the surfaces of injured endothelium and activated platelets, where clotting factors are being activated. This leads to the formation of a fibrin mesh which provides stability to the formed platelet plug to allow wound healing.

Tertiary hemostasis

Fibrinolysis breaks down the platelet plug that allows normal structure of the endothelium, smooth endothelial lining, and normal lumen size.

Disorders of hemostasis, or an imbalance in the blood's clotting process, can both result in either hypocoagulation (bleeding) or hypercoagulation (thromboembolic disorders). Hereditary bleeding disorders are caused by the absence or deficiency of specific clotting proteins. The most common hereditary bleeding disorders are hemophilia A, hemophilia B, von Willebrand disease and immune thrombocytopenia (ITP).

Hemostasis has now been widely studied for more than a century. Life science research has generated a very detailed picture of the molecular and cellular events that play roles in normal and pathological hemostasis. Novel medication for treatment of hemostatic disorders is still a significant area of interest, taking hemophilia treatment as an example.

 

Explore the latest programmes to support your clinical decision-making.